Clinically, ANXA3 overexpression has been demonstrated to be correlated with the occurrence of lymph node metastasis and the clinicopathological stages of breast cancer (Zhou et al., 2017b) and lung adenocarcinoma (Liu et al., 2009). The gene discussed is ANXA3; the disease is breast cancer.